Education
About Us
Working with TipRanks
Follow Us
Richard Nolan Townsend Insider Profile
4 Followers
Richard Nolan Townsend, CEO, Director at Lexeo Therapeutics, Inc., holds 220.12K shares in Lexeo Therapeutics, Inc. (Ticker: LXEO). Most recently, Richard Nolan Townsend Sold $4,326 shares of Lexeo Therapeutics, Inc. on Feb 21, 2025 for an estimated value of 19.08K.
Richard Nolan Townsend has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Richard Nolan Townsend's holdings
Insider Roles
CEO, Director
Roles that Richard Nolan Townsend holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Richard Nolan Townsend
Richard Nolan Townsend's Trading History
List of latest transactions for each holding click on a transaction to see Richard Nolan Townsend's performance on stock
You May Also Like
Richard Nolan Townsend insider profile FAQ
What is the percentage of profitable transactions made by Richard Nolan Townsend?
The percentage of profitable transactions made by Richard Nolan Townsend is ―.
What is the average return per transaction made by Richard Nolan Townsend?
The average return per transaction made by Richard Nolan Townsend is ―.
What stocks does Richard Nolan Townsend hold?
Richard Nolan Townsend holds: LXEO stocks.
What was Richard Nolan Townsend’s latest transaction?
Richard Nolan Townsend latest transaction was an Informative Sell of $19.08K.
What was Richard Nolan Townsend's most profitable transaction?
Richard Nolan Townsend’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Richard Nolan Townsend's role in Lexeo Therapeutics, Inc.?
Richard Nolan Townsend's role in Lexeo Therapeutics, Inc. is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.